StockData

China SXT Pharmaceuticals, Inc. (SXTC) bonds

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.86−0.13 (-4.35%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

Debt

Borrowings on the balance sheet, Mar 31, 2026

Total debt
$999.57K
$355.18K due within a year
Net debt
-$27.18M
After $28.18M of cash
Implied interest rate
6.97%
FY2026 interest ÷ average debt
Interest coverage
-113.1×
FY2026 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Mar 31, 2026

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in China SXT Pharmaceuticals's 20-F for the period ended Mar 31, 2026

IssueCarrying value
Bank Loans$96.26K
Car Loans$8.78K
Convertible Note20222new
Convertible
$235.36K
Convertible Note20232
Convertible
$19.59K
Convertible Note2024
Convertible
$235.91K
Convertible Note2024 One
Convertible
$71.93K
Convertible Note20242
Convertible
$55.51K
Convertible Note20242 One
Convertible
$98.94K
Convertible Note20243
Convertible
$640
Convertible Note20243 One
Convertible
$381.06K
Other Loans$644.39K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 20-F.

See a number that looks wrong?